Course curriculum

    1. Syllabus

    2. Clarifying Relevant Terms

    3. Abortion Pill Regimen : What is the Situation in Canada?

    4. APR News: Waiting on SOGC's Statement

    1. "Health Canada approves updates to Mifegymiso prescribing information: Ultrasound no longer mandatory" article by Health Canada

    2. The American Context: "Dangers of Relaxed Restrictions on Mifepristone" committee opinion by AAPLOG

    1. "Chemical Abortion and Reversal Options" CPL 2022 conference video ft. C Francis

    2. "Progesterone Use to Reverse the Effects of Mifepristone" 2012 Case Report by G Delgado & M Davenport (4 pages)

    3. "Embryo Survival after Mifepristone: A Systematic Review of the Literature" 2017 article by G Delgado et al. (17 pages)

    4. OVERVIEW: 2018 Delgado "A Case Series" Study

    5. "A Case Series Detailing the Successful Reversal of the Effects of Mifepristone Using Progesterone" 2018 article by G Delgado et al. (12 pages)

    6. OVERVIEW: 2019 Creinin "Mifepristone Antagonization" Study

    7. "Mifepristone Antagonization With Progesterone" 2019 Study by M Creinin et al. (8 pages)

    8. "Mifepristone Antagonization With Progesterone" 2020 Letter Response by G Delgado et al. (2 pages)

    9. Summary from APRN and Heart Beat International

    1. Get Connected: Abortion Pill Rescue Network (APRN) in Canada

    2. Request an APR Healthcare Professional Kit from Heartbeat International

    3. Progesterone Protocols for The Attempted Reversal of Mifepristone

    4. Progesterone Drug Formulary Status

    5. "Reversal of the Effects of Mifepristone by Progesterone" practice guideline by AAPLOG

    6. FAQs from the Abortion Reversal Provider Network

    7. Progesterone for Prevention of Pre-term birth (off label use) Drug Facts

    1. Key Take-Aways

    2. Tool Kit from HeartBeat International

    3. Abortion Pill Reversal Bibliography

    4. Supplementary Readings

About this course

  • $5.00
  • 26 lessons
  • 0.5 hours of video content